Factors associated with primary resistance to enfortumab vedotin in previously treated patients with metastatic urothelial carcinoma: a multicenter retrospective study.
Saved in:
| Title: | Factors associated with primary resistance to enfortumab vedotin in previously treated patients with metastatic urothelial carcinoma: a multicenter retrospective study. |
|---|---|
| Authors: | Ikarashi D; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan. dikara@iwate-med.ac.jp., Hayakawa N; Department of Urology, St. Marianna University School of Medicine, Kanagawa, Japan., Kaneko G; Department of Uro-Oncology, Saitama Medical University International Medical Center, Saitama, Japan., Sakura Y; Division of Urology, Shizuoka Cancer Center, Shizuoka, Japan., Endo Y; Department of Urology, Nippon Medical School, Tokyo, Japan., Yamashita R; Division of Urology, Shizuoka Cancer Center, Shizuoka, Japan., Shirotake S; Department of Uro-Oncology, Saitama Medical University International Medical Center, Saitama, Japan., Kondo Y; Department of Urology, Nippon Medical School, Tokyo, Japan., Kikuchi E; Department of Urology, St. Marianna University School of Medicine, Kanagawa, Japan., Obara W; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan. |
| Source: | International journal of clinical oncology [Int J Clin Oncol] 2025 Sep; Vol. 30 (9), pp. 1841-1848. Date of Electronic Publication: 2025 Jul 07. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
